Skip to content

Preferred Stock at other companies

United Therapeutics logo
United TherapeuticsUTHR
$0
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$0
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0
Zymeworks logo
ZymeworksZYME
$0
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$0
LQD
Liquidia CorporationLQDA
$0

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+20.6%
Enterprise value$1.14B
P/S6,001×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Ethos Technologies, Inc. ’s 10-K, filed March 24, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.